|Systematic (IUPAC) name|
|Mol. mass||330.21 g/mol|
AB-PINACA is a compound that was first identified as a component of synthetic cannabis products in Japan in 2012. The pharmacological properties of this compound have not been formally studied or reported in the scientific literature, but it is presumably a cannabinoid agonist as it was found alongside a structurally related compound AB-FUBINACA which had previously been reported as a cannabinoid agonist in a 2009 Pfizer patent.
- Uchiyama, N.; Matsuda, S.; Wakana, D.; Kikura-Hanajiri, R.; Goda, Y. (2012). "New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products". Forensic Toxicology 31: 93. doi:10.1007/s11419-012-0171-4.
- Buchler IP et al, INDAZOLE DERIVATIVES. WO 2009/106980
- Buchler IP et al, INDAZOLE DERIVATIVES. WO 2009/106982
|This cannabinoid related article is a stub. You can help Wikipedia by expanding it.|